Viveve Medical, Inc. (VIVE)
USD 0.0
(100.0%)
USD 0.0
(100.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2021 | 22.17 Million USD | 18.0% |
| 2020 | 18.79 Million USD | -39.29% |
| 2019 | 30.95 Million USD | -40.8% |
| 2018 | 52.28 Million USD | 26.99% |
| 2017 | 41.17 Million USD | 93.92% |
| 2016 | 21.23 Million USD | 70.52% |
| 2015 | 12.45 Million USD | 118.38% |
| 2014 | 5.7 Million USD | 4.68% |
| 2013 | 5.44 Million USD | 16.79% |
| 2012 | 4.66 Million USD | 27.54% |
| 2011 | 3.65 Million USD | 16.54% |
| 2010 | 3.13 Million USD | -26.03% |
| 2009 | 4.24 Million USD | -19.03% |
| 2008 | 5.23 Million USD | -15.17% |
| 2007 | 6.17 Million USD | 76.16% |
| 2006 | 3.5 Million USD | -42.39% |
| 2005 | 6.08 Million USD | 11.49% |
| 2004 | 5.45 Million USD | 27.64% |
| 2003 | 4.27 Million USD | -5.27% |
| 2002 | 4.51 Million USD | -45.88% |
| 2001 | 8.34 Million USD | -43.45% |
| 2000 | 14.75 Million USD | -2.34% |
| 1999 | 15.1 Million USD | -29.42% |
| 1998 | 21.4 Million USD | 5.94% |
| 1997 | 20.2 Million USD | 83.64% |
| 1996 | 11 Million USD | 39.24% |
| 1995 | 7.9 Million USD | 41.07% |
| 1994 | 5.6 Million USD | 16.67% |
| 1993 | 4.8 Million USD | 26.32% |
| 1992 | 3.8 Million USD | 90.0% |
| 1991 | 2 Million USD | 1900.0% |
| 1990 | 100 Thousand USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2022 Q3 | 5.2 Million USD | -1.99% |
| 2022 Q2 | 5.31 Million USD | -8.27% |
| 2022 Q1 | 5.79 Million USD | -2.57% |
| 2021 Q2 | 5.11 Million USD | -7.28% |
| 2021 Q3 | 5.6 Million USD | 9.71% |
| 2021 Q4 | 5.94 Million USD | 6.06% |
| 2021 FY | 22.17 Million USD | 18.0% |
| 2021 Q1 | 5.51 Million USD | 20.59% |
| 2020 Q3 | 3.64 Million USD | -20.31% |
| 2020 Q1 | 6 Million USD | -13.44% |
| 2020 Q2 | 4.57 Million USD | -23.79% |
| 2020 Q4 | 4.57 Million USD | 25.38% |
| 2020 FY | 18.79 Million USD | -39.29% |
| 2019 Q3 | 6.48 Million USD | -23.14% |
| 2019 Q1 | 9.1 Million USD | -34.64% |
| 2019 Q4 | 6.93 Million USD | 6.99% |
| 2019 Q2 | 8.43 Million USD | -7.4% |
| 2019 FY | 30.95 Million USD | -40.8% |
| 2018 Q3 | 12.55 Million USD | -4.22% |
| 2018 Q1 | 12.68 Million USD | 3.98% |
| 2018 Q2 | 13.1 Million USD | 3.33% |
| 2018 FY | 52.28 Million USD | 26.99% |
| 2018 Q4 | 13.93 Million USD | 10.97% |
| 2017 Q1 | 7.83 Million USD | 20.86% |
| 2017 FY | 41.17 Million USD | 93.92% |
| 2017 Q4 | 12.2 Million USD | 12.63% |
| 2017 Q3 | 10.83 Million USD | 5.15% |
| 2017 Q2 | 10.3 Million USD | 31.44% |
| 2016 Q3 | 5.32 Million USD | 4.88% |
| 2016 Q4 | 6.48 Million USD | 21.76% |
| 2016 Q1 | 4.34 Million USD | 12.8% |
| 2016 Q2 | 5.07 Million USD | 16.9% |
| 2016 FY | 21.23 Million USD | 70.52% |
| 2015 Q2 | 2.9 Million USD | 20.02% |
| 2015 Q3 | 3.27 Million USD | 12.56% |
| 2015 Q1 | 2.42 Million USD | 44.56% |
| 2015 FY | 12.45 Million USD | 118.38% |
| 2015 Q4 | 3.85 Million USD | 17.7% |
| 2014 Q3 | 2.36 Million USD | 90.5% |
| 2014 FY | 5.7 Million USD | 4.68% |
| 2014 Q1 | 996 Thousand USD | -16.37% |
| 2014 Q2 | 1.24 Million USD | 24.5% |
| 2014 Q4 | 1.67 Million USD | -29.07% |
| 2013 Q3 | 1.49 Million USD | -1.9% |
| 2013 Q1 | 1.23 Million USD | 8.02% |
| 2013 FY | 5.44 Million USD | 16.79% |
| 2013 Q4 | 1.19 Million USD | -20.28% |
| 2013 Q2 | 1.52 Million USD | 22.92% |
| 2012 Q3 | 1.22 Million USD | 9.39% |
| 2012 Q2 | 1.11 Million USD | -4.93% |
| 2012 Q1 | 1.17 Million USD | 8.09% |
| 2012 FY | 4.66 Million USD | 27.54% |
| 2012 Q4 | 1.14 Million USD | -6.21% |
| 2011 Q4 | 1.08 Million USD | 20.49% |
| 2011 FY | 3.65 Million USD | 16.54% |
| 2011 Q2 | 1.04 Million USD | -13.04% |
| 2011 Q1 | 1.19 Million USD | 153.39% |
| 2011 Q3 | 903 Thousand USD | -13.17% |
| 2010 FY | 3.13 Million USD | -26.03% |
| 2010 Q3 | 660 Thousand USD | -30.67% |
| 2010 Q1 | 1.05 Million USD | 7.44% |
| 2010 Q2 | 952 Thousand USD | -9.68% |
| 2010 Q4 | 472 Thousand USD | -28.48% |
| 2009 Q3 | 882 Thousand USD | -17.18% |
| 2009 Q1 | 1.31 Million USD | 20.22% |
| 2009 Q4 | 981 Thousand USD | 11.22% |
| 2009 FY | 4.24 Million USD | -19.03% |
| 2009 Q2 | 1.06 Million USD | -18.95% |
| 2008 Q1 | 1.57 Million USD | 0.32% |
| 2008 FY | 5.23 Million USD | -15.17% |
| 2008 Q4 | 1.09 Million USD | -3.7% |
| 2008 Q3 | 1.13 Million USD | -20.8% |
| 2008 Q2 | 1.43 Million USD | -9.19% |
| 2007 FY | 6.17 Million USD | 76.16% |
| 2007 Q4 | 1.57 Million USD | 7.23% |
| 2007 Q2 | 1.63 Million USD | 8.51% |
| 2007 Q1 | 1.5 Million USD | 38.87% |
| 2007 Q3 | 1.46 Million USD | -10.11% |
| 2006 Q2 | 1.26 Million USD | 6742.11% |
| 2006 FY | 3.5 Million USD | -42.39% |
| 2006 Q1 | -19 Thousand USD | -101.23% |
| 2006 Q4 | 1.08 Million USD | -8.22% |
| 2006 Q3 | 1.18 Million USD | -6.5% |
| 2005 FY | 6.08 Million USD | 11.49% |
| 2005 Q4 | 1.54 Million USD | -0.58% |
| 2005 Q3 | 1.54 Million USD | 0.19% |
| 2005 Q1 | 1.45 Million USD | 37.41% |
| 2005 Q2 | 1.54 Million USD | 6.55% |
| 2004 Q3 | 1.5 Million USD | 8.68% |
| 2004 Q2 | 1.38 Million USD | -9.02% |
| 2004 Q1 | 1.51 Million USD | 59.06% |
| 2004 FY | 5.45 Million USD | 27.64% |
| 2004 Q4 | 1.05 Million USD | -29.69% |
| 2003 Q2 | 1.19 Million USD | 8.93% |
| 2003 FY | 4.27 Million USD | -5.27% |
| 2003 Q3 | 1.03 Million USD | -13.81% |
| 2003 Q4 | 955 Thousand USD | -7.28% |
| 2003 Q1 | 1.09 Million USD | 3.49% |
| 2002 Q4 | 1.06 Million USD | 3.31% |
| 2002 FY | 4.51 Million USD | -45.88% |
| 2002 Q3 | 1.02 Million USD | -11.63% |
| 2002 Q2 | 1.16 Million USD | -8.44% |
| 2002 Q1 | 1.26 Million USD | -5.02% |
| 2001 Q4 | 1.33 Million USD | -37.82% |
| 2001 Q3 | 2.14 Million USD | -10.17% |
| 2001 Q2 | 2.39 Million USD | -3.24% |
| 2001 Q1 | 2.47 Million USD | -44.28% |
| 2001 FY | 8.34 Million USD | -43.45% |
| 2000 Q1 | 3.66 Million USD | -6.17% |
| 2000 Q2 | 3.49 Million USD | -4.67% |
| 2000 Q3 | 3.16 Million USD | -9.42% |
| 2000 Q4 | 4.43 Million USD | 40.15% |
| 2000 FY | 14.75 Million USD | -2.34% |
| 1999 Q4 | 3.9 Million USD | 34.62% |
| 1999 Q3 | 2.9 Million USD | -27.5% |
| 1999 Q2 | 4 Million USD | -6.98% |
| 1999 Q1 | 4.3 Million USD | -24.56% |
| 1999 FY | 15.1 Million USD | -29.42% |
| 1998 Q1 | 4.9 Million USD | -19.67% |
| 1998 Q3 | 4.9 Million USD | -15.52% |
| 1998 Q4 | 5.7 Million USD | 16.33% |
| 1998 FY | 21.4 Million USD | 5.94% |
| 1998 Q2 | 5.8 Million USD | 18.37% |
| 1997 Q2 | 5 Million USD | 16.28% |
| 1997 Q3 | 4.8 Million USD | -4.0% |
| 1997 FY | 20.2 Million USD | 83.64% |
| 1997 Q1 | 4.3 Million USD | 22.86% |
| 1997 Q4 | 6.1 Million USD | 27.08% |
| 1996 Q1 | 2.5 Million USD | 121.01% |
| 1996 Q4 | 3.5 Million USD | 29.63% |
| 1996 Q3 | 2.7 Million USD | 8.0% |
| 1996 Q2 | 2.5 Million USD | 0.0% |
| 1996 FY | 11 Million USD | 39.24% |
| 1995 Q2 | - USD | 0.0% |
| 1995 Q3 | - USD | 0.0% |
| 1995 Q4 | -11.9 Million USD | 0.0% |
| 1995 Q1 | - USD | -100.0% |
| 1995 FY | 7.9 Million USD | 41.07% |
| 1994 Q1 | 1.5 Million USD | 15.38% |
| 1994 FY | 5.6 Million USD | 16.67% |
| 1994 Q3 | 1.4 Million USD | 16.67% |
| 1994 Q4 | 1.6 Million USD | 14.29% |
| 1994 Q2 | 1.2 Million USD | -20.0% |
| 1993 Q4 | 1.3 Million USD | 18.18% |
| 1993 FY | 4.8 Million USD | 26.32% |
| 1993 Q1 | 1.1 Million USD | 0.0% |
| 1993 Q2 | 1.3 Million USD | 18.18% |
| 1993 Q3 | 1.1 Million USD | -15.38% |
| 1992 Q4 | 1.1 Million USD | 22.22% |
| 1992 Q1 | 800 Thousand USD | 140.0% |
| 1992 Q3 | 900 Thousand USD | -18.18% |
| 1992 Q2 | 1.1 Million USD | 37.5% |
| 1992 FY | 3.8 Million USD | 90.0% |
| 1991 Q4 | -2 Million USD | 0.0% |
| 1991 Q2 | - USD | 0.0% |
| 1991 Q3 | - USD | 0.0% |
| 1991 Q1 | - USD | 100.0% |
| 1991 FY | 2 Million USD | 1900.0% |
| 1990 FY | 100 Thousand USD | 0.0% |
| 1990 Q3 | - USD | 0.0% |
| 1990 Q2 | - USD | 0.0% |
| 1990 Q1 | - USD | 0.0% |
| 1990 Q4 | -100 Thousand USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -97.55% |
| Cerus Corporation | 143.15 Million USD | 84.511% |
| OrthoPediatrics Corp. | 137.01 Million USD | 83.818% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -95.17% |
| Talis Biomedical Corporation | 67.18 Million USD | 66.998% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | 11.116% |
| Inogen, Inc. | 236.08 Million USD | 90.608% |
| Spectral AI, Inc. | 20.86 Million USD | -6.274% |
| Nano-X Imaging Ltd. | 55.99 Million USD | 60.403% |
| CVRx, Inc. | 76.14 Million USD | 70.879% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -528.487% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -77.54% |
| Orthofix Medical Inc. | 667.42 Million USD | 96.678% |
| Venus Concept Inc. | 80.47 Million USD | 72.448% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | 60.81% |
| Bioventus Inc. | 409.91 Million USD | 94.591% |
| BrainsWay Ltd. | 28.01 Million USD | 20.862% |
| Envoy Medical, Inc. | 17.89 Million USD | -23.885% |
| electroCore, Inc. | 32.03 Million USD | 30.776% |
| IceCure Medical Ltd | 16.87 Million USD | -31.388% |
| Lucid Diagnostics Inc. | 42.43 Million USD | 47.745% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | -25.747% |
| MaxCyte, Inc. | 84.84 Million USD | 73.866% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -78.645% |
| Nexalin Technology, Inc. | 5.78 Million USD | -283.526% |
| PAVmed Inc | 64.82 Million USD | 65.797% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | 56.59% |
| RxSight, Inc. | 103.85 Million USD | 78.649% |
| Sight Sciences, Inc. | 126.44 Million USD | 82.465% |
| SI-BONE, Inc. | 156.35 Million USD | 85.818% |
| TELA Bio, Inc. | 84.18 Million USD | 73.662% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | 68.35% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 89.097% |
| LivaNova PLC | 843.54 Million USD | 97.371% |
| 908 Devices Inc. | 68.08 Million USD | 67.431% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 95.415% |
| Nemaura Medical Inc. | 7.13 Million USD | -210.598% |
| NeuroPace, Inc. | 75.29 Million USD | 70.552% |
| LENSAR, Inc. | 33.33 Million USD | 33.486% |
| Apyx Medical Corporation | 51.01 Million USD | 56.539% |
| Cutera, Inc. | 197.72 Million USD | 88.786% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | 10.524% |
| BioSig Technologies, Inc. | 28.53 Million USD | 22.282% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 88.42% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | 38.511% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 97.349% |
| Axonics, Inc. | 270.2 Million USD | 91.794% |
| Outset Medical, Inc. | 198.77 Million USD | 88.845% |
| IRIDEX Corporation | 31.81 Million USD | 30.304% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 87.697% |
| IRadimed Corporation | 30.12 Million USD | 26.391% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -159.88% |
| INVO Bioscience, Inc. | 7.85 Million USD | -182.34% |
| Telesis Bio, Inc. | 63.48 Million USD | 65.076% |
| Viemed Healthcare, Inc. | 98.45 Million USD | 77.479% |
| Varex Imaging Corporation | 224.8 Million USD | 90.137% |
| Quipt Home Medical Corp. | 148.66 Million USD | 85.085% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -89.141% |
| Pulmonx Corporation | 112.68 Million USD | 80.323% |
| Dynatronics Corporation | 9.9 Million USD | -123.788% |
| Modular Medical, Inc. | 17.52 Million USD | -26.493% |
| ReShape Lifesciences Inc. | 20.18 Million USD | -9.838% |
| Semler Scientific, Inc. | 38.94 Million USD | 43.064% |
| InMode Ltd. | 215.68 Million USD | 89.719% |
| Bruker Corporation | 1.07 Billion USD | 97.94% |
| Cytosorbents Corporation | 48.33 Million USD | 54.128% |
| DexCom, Inc. | 1.69 Billion USD | 98.689% |
| Align Technology, Inc. | 2.07 Billion USD | 98.932% |
| ZimVie Inc. | 275.12 Million USD | 91.941% |
| Movano Inc. | 29.69 Million USD | 25.318% |
| Cytek Biosciences, Inc. | 137.27 Million USD | 83.847% |
| Nexalin Technology, Inc. | 5.78 Million USD | -283.526% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -528.487% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 96.31% |
| Profound Medical Corp. | 33.6 Million USD | 34.015% |
| Insulet Corporation | 939.9 Million USD | 97.641% |
| enVVeno Medical Corporation | 25.23 Million USD | 12.144% |
| Surmodics, Inc. | 98.69 Million USD | 77.534% |
| iCAD, Inc. | 22.22 Million USD | 0.234% |
| Nuwellis, Inc. | 22.61 Million USD | 1.946% |
| Biotricity, Inc. | 17.18 Million USD | -29.029% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 95.027% |
| Aethlon Medical, Inc. | 12.27 Million USD | -80.598% |
| InspireMD, Inc. | 22.95 Million USD | 3.386% |
| PAVmed Inc. | 64.82 Million USD | 65.797% |
| BIOLASE, Inc. | 34.66 Million USD | 36.029% |
| Beyond Air, Inc. | 61.7 Million USD | 64.063% |
| FONAR Corporation | 28.6 Million USD | 22.485% |
| AxoGen, Inc. | 149.33 Million USD | 85.152% |
| Vivani Medical, Inc. | 26.96 Million USD | 17.771% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 87.479% |
| Inari Medical, Inc. | 448.59 Million USD | 95.057% |
| UFP Technologies, Inc. | 58.08 Million USD | 61.829% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -349.976% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -250.934% |
| Tenon Medical, Inc. | 16.96 Million USD | -30.675% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -199.919% |
| Co-Diagnostics, Inc. | 44.1 Million USD | 49.724% |
| AdaptHealth Corp. | 1.07 Billion USD | 97.943% |
| Sintx Technologies, Inc. | 15.2 Million USD | -45.865% |
| NanoVibronix, Inc. | 4.97 Million USD | -345.868% |
| Quanterix Corporation | 118.1 Million USD | 81.225% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -89.141% |
| Sensus Healthcare, Inc. | 14.44 Million USD | -53.531% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 94.353% |
| TransMedics Group, Inc. | 182.82 Million USD | 87.872% |
| ReWalk Robotics Ltd. | 28.06 Million USD | 20.994% |
| NeuroMetrix, Inc. | 11.09 Million USD | -99.776% |
| Hyperfine, Inc. | 52.87 Million USD | 58.063% |
| Establishment Labs Holdings Inc. | 172 Million USD | 87.109% |
| Biomerica, Inc. | 6.97 Million USD | -217.756% |
| Bone Biologics Corporation | 9.42 Million USD | -135.175% |
| AVITA Medical, Inc. | 80.77 Million USD | 72.551% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -115.038% |
| Silk Road Medical, Inc | 186.35 Million USD | 88.102% |